Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/16/1983 | EP0093805A1 Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1H-isoindole-1-carboxylic acids and esters |
11/16/1983 | EP0093776A1 Monoclonal antibodies against schistosoma |
11/16/1983 | EP0093775A1 Monoclonal antibodies against brugia malayi |
11/16/1983 | EP0093774A1 Monoclonal antibodies against leishmania |
11/15/1983 | US4415558 CRF And analogs |
11/15/1983 | US4415557 Antibiotic compound, its production and its medicinal use |
11/15/1983 | US4415546 Biologically active analogs of ACTH and radioimmuno assay therefor |
11/15/1983 | US4415496 Bicyclic lactams |
11/15/1983 | US4415493 Immune modulator peptides |
11/15/1983 | US4414976 Tissue adhesive |
11/15/1983 | CA1157030A1 .alpha.-VINYL AMINO ACIDS |
11/15/1983 | CA1157015A1 Polypeptide and its production and use |
11/15/1983 | CA1156931A1 Method of enzymatic debridement |
11/10/1983 | WO1983003763A1 Process for preparing l-asparaginase-immobilizing agent for teating leucemia |
11/10/1983 | WO1983003760A1 Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy |
11/09/1983 | EP0093652A1 Synthetic toxin ST, process for its preparation and its use as a vaccination agent |
11/09/1983 | EP0093619A1 Human tissue plasminogen activator, pharmaceutical compositions containing it, processes for making it, and DNA and transformed cell intermediates therefor |
11/09/1983 | EP0093551A2 Pharmaceutical composition |
11/09/1983 | EP0093436A2 Process for preparing permanent animal and human cell lines, and their use |
11/08/1983 | US4414212 Method of treatment of pre-menstrual syndrome |
11/08/1983 | US4414205 Dolastatin, antitumor |
11/08/1983 | US4414204 With a muramyl-peptide |
11/08/1983 | US4414201 Immunopotentiator containing abrin |
11/08/1983 | US4414150 Hybrid human leukocyte interferons |
11/08/1983 | US4414149 Glycine8 -D-arginine24 calcitonin |
11/08/1983 | US4414148 Anti-cancer drugs for the treatment of melanomas and method for preparing thereof |
11/08/1983 | US4414147 Methods of decreasing the hydrophobicity of fibroblast and other interferons |
11/08/1983 | CA1156529A1 Fibrous collagenous hemostatic-adhesive webs |
11/02/1983 | EP0092942A2 Peptide derivatives, their production and use |
11/02/1983 | EP0092918A2 Continuous release formulations |
11/02/1983 | EP0092583A1 Telecommunications cable and method of making same. |
11/01/1983 | US4413141 Inhibitor of ornithine decarboxylase |
11/01/1983 | US4412990 Composition having enhanced opsonic activity |
11/01/1983 | US4412989 Oxygen carrier |
11/01/1983 | US4412988 Hexapeptides |
11/01/1983 | US4412985 Depyrogenation process |
11/01/1983 | US4412946 Immunostimulating glycoproteins |
11/01/1983 | CA1156222A1 Angiotensin-ii analogues with antagonizing effects, containing an ester group in position 8, and a process for the preparation thereof |
11/01/1983 | CA1156221A1 Processes for the preparation of new biologically active peptides |
11/01/1983 | CA1156219A1 Analgesic compounds |
11/01/1983 | CA1156218A1 Antibiotic a-30912 factor h |
11/01/1983 | CA1156217A1 Insulin derivatives and process for the preparation thereof |
11/01/1983 | CA1156145A1 Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid, for induction of interferon in primates |
10/26/1983 | EP0092280A1 Semi-synthetic preparation of human insulin |
10/26/1983 | EP0092186A2 Method of preparing gamma globulin suitable for intravenous administration |
10/26/1983 | EP0092182A2 Preparation of functional human urokinase polypeptides |
10/26/1983 | EP0092163A2 Purification of interleukin 2 |
10/26/1983 | EP0091952A1 Cell-seeding procedures involving fibrous lattices. |
10/26/1983 | EP0091950A1 Method of reducing the level of low density lipoproteins in the serum of a patient |
10/25/1983 | US4411992 Process for preparing murine interleukin 2 |
10/25/1983 | US4411915 Heme-iron-enriched amino acid and a process for the preparation of heme-iron-enriched amino acid |
10/25/1983 | US4411890 Synthetic peptides having pituitary growth hormone releasing activity |
10/25/1983 | US4411794 Adsorption on minerals |
10/19/1983 | EP0091784A2 Products for use in treating cancer |
10/19/1983 | EP0091745A1 Preparation of an antibiotic selectively effective against staphylococcus infections |
10/19/1983 | EP0091611A1 Anti-caries chewing gum |
10/19/1983 | EP0091543A1 Anti-interferon antibodies and method of producing same |
10/19/1983 | EP0091527A2 DNA sequences, recombinant DNA molecules and processes for producing human serum albumin-like polypeptides |
10/18/1983 | US4410531 Treatment of myocardial infaction |
10/18/1983 | US4410520 Angiotension converting enzyme ingibitor, hypotensive agents |
10/18/1983 | US4410513 Synthetic peptides having pituitary growth hormone releasing activity |
10/18/1983 | US4410512 Combinations having synergistic pituitary growth hormone releasing activity |
10/18/1983 | US4410511 Endorphin antagonist |
10/18/1983 | US4410246 System and mechanism of feeding, traction, shuttering and film adjustment in programmable audiovisual apparatus, with rapid frame change |
10/18/1983 | CA1155439A1 Insulin crystal suspension and process for the preparation thereof |
10/13/1983 | WO1983003414A1 Steroid esters of n-(2-halogenoethyl)-n-nitroso-carbamoyl-amino acids and peptides thereof |
10/12/1983 | EP0091258A2 Method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing said factor |
10/12/1983 | EP0091240A2 Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them |
10/12/1983 | EP0091183A2 Functional oxygen transport system |
10/12/1983 | EP0090997A2 Adhesive wound covering material comprising collagen |
10/12/1983 | EP0090892A1 Process for the purification of physiologically active substance having antitumour activity |
10/12/1983 | EP0090886A2 Stabilization of influenza virus vaccine |
10/12/1983 | EP0090837A1 Method and composition for treating a patient suffering from interferonsusceptible disorder |
10/11/1983 | US4409335 Method for eliminating glucose dependent Schiff base effect from hemoglobin A1 assay |
10/11/1983 | US4409331 Preparation of substances with encapsulated cells |
10/11/1983 | US4409210 Antibiotic compound |
10/11/1983 | US4409208 GnRH antagonists |
10/11/1983 | US4409141 Peptides for assaying human parathyroid hormone |
10/11/1983 | US4409139 Gonadostatin |
10/11/1983 | US4409138 Non-absorbable compounds of mucolytic activity, the process for their preparation, and therapeutic compositions which contain them as active principle |
10/11/1983 | US4408443 Telecommunications cable and method of making same |
10/11/1983 | CA1155109A1 Process for producing an insulin |
10/11/1983 | CA1155057A1 Vaccine and method of making |
10/05/1983 | EP0090732A1 Proteic product, its obtention and use as a medicament, in particular an immuno regulator and anti-allergic agent |
10/05/1983 | EP0090578A2 A41030 antibiotics and their production |
10/05/1983 | EP0090505A2 Human antithrombin III, DNA sequences therefor, expression vehicles and cloning vectors containing such sequences and cell cultures transformed thereby, a process for expressing human antithrombin III, and pharmaceutical compositions comprising it |
10/05/1983 | EP0090388A1 Chromophore peptides, process for their preparation, agents containing them and their use in the detection of DD-carboxy peptidases |
10/05/1983 | EP0090362A2 Derivatives of cycloalka(c)pyrrole-carboxylic acids, process for their preparation, agents containing them and their use, as well as cycloalka(c)pyrrole-carboxylic acids as intermediates, and process for their preparation |
10/05/1983 | EP0090341A2 Spiro-(4,(3+n))-2-aza-alkan-3-carboxylic-acid derivatives, process for their preparation,agents containing them and their use |
10/05/1983 | EP0089950A1 Polypeptide, preparation method thereof, utilization thereof and pharmaceutical products containing it |
10/04/1983 | US4407794 Peptides and therapeutic applications thereof |
10/04/1983 | US4407787 Reactive sulfhydryl groups |
10/04/1983 | US4407746 Cyclohexyl and phenyl substituted enkephalins |
10/04/1983 | US4407744 Plasminogen activator |
10/04/1983 | CA1154758A1 Water-soluble peptides affecting gonadal function |
10/04/1983 | CA1154695A1 Method of producing the a-30912 antibiotics |
10/04/1983 | CA1154678A1 Pharmaceutical composition for parenteral nutrition comprising l-carnitine or acyl l-carnitines |
10/04/1983 | CA1154672A1 Chromium acetylacetonate as a dietary supplement and pharmaceutical agent |
10/04/1983 | CA1154671A1 Separation of a tissular activator of plasminogen |
09/30/1983 | EP0077354A4 Dialysis solution containing glucose, amino acids & insulin. |